Manus Neurodynamica is a pioneering brand that is revolutionizing the way we diagnose and monitor neuromotor impairments. They have developed a unique and patented concept called the NeuroMotor Pen (NMP), which combines movement-related sensor technologies with a digital pen and an analytical engine. Using the NMP, patients perform standardized handwriting and drawing tasks on a tablet computer, which non-invasively records parameters of minute limb and hand motions.

This data is then analyzed using Manus Neurodynamica's diagnostic algorithms, which differentiate between movements and provide accurate biomarkers of neuromotor impairments. What sets Manus Neurodynamica apart is their dedication to expertise, technology, privacy, and respect. They aim to improve the well-being of patients by offering convenient and reliable diagnosis and disease management solutions.

They follow strict data management protocols to ensure patient privacy, and their cloud-based facility is secure and provided by SmartPoints™. With a team of experienced professionals and a board of directors with extensive backgrounds in healthcare and neuroscience, Manus Neurodynamica is at the forefront of innovation in the field of neuromotor impairments